Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.003 USD | +2.35% | -0.69% | -19.76% |
Mar. 21 | Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M | MT |
Mar. 21 | Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.76% | 58.89M | |
+1.90% | 42.59B | |
+7.87% | 40.65B | |
+48.77% | 40.57B | |
-11.96% | 26.77B | |
+8.78% | 24.81B | |
-24.35% | 18.17B | |
+28.11% | 12.05B | |
-3.11% | 11.7B | |
+7.21% | 11.1B |
- Stock Market
- Equities
- KRON Stock
- News Kronos Bio, Inc.
- Kronos Bio : FDA OKs Kronos Bio's Investigational New Drug Application for Advanced Solid Tumor Treatment